Session Details
Joint Symposium 3：The frontiers of targeted radionuclide therapy
Sat. Apr 18, 2026 1:30 PM - 3:30 PM JST
Sat. Apr 18, 2026 4:30 AM - 6:30 AM UTC
Sat. Apr 18, 2026 4:30 AM - 6:30 AM UTC
National Convention Hall
Chairperson:Makoto Hosono(Kindai University Faculty of Medicine), Kenta Miwa(Fukushima Medical University)
[CSY3-1]NEA’s vision and expectations for the global promotion of Targeted Radionuclide Therapy (TRT) utilizing nuclear energy
William D. Magwood, IV (OECD Nuclear Energy Agency (NEA))
[CSY3-2]The Cutting-Edge of Targeted Radioligand Therapy in Japan and Worldwide
Tadashi Watabe (The University of Osaka)
[CSY3-3]A cutting edges technology of dosimetry for radionuclide therapy
Naoyuki Ukon (Fukushima Medical University)
[CSY3-4]Radionuclide production for radio-therapy: Current status in Japan
Kotaro Nagatsu (Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology)
[CSY3-5]Radiation Regulation and the Challenges of Targeted Radionuclide Therapy
Tatsuya Higashi (Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology)